new glp 1 receptor agonists GLP-1 as Treatments for Type 2 Diabetes Structures of formulations of GLP-1

Discover how microdosing GLP-1s can have low side effects, low costs, and support weight loss

Mattioli Introduction GLP-1 agonists like liraglutide have become a powerful tool for weight management, but they often come with digestive side effects and concerns about long-term use

The magnitude of the benefits of GLP-1RA and SGLT-2 inhibitors on MACE are similar, ranging from 12 to 14% reduction of risk, but only GLP-1RA may reduce the risk of stroke

Aspiration of gastric contents can still occur despite appropriate preoperative fasting in patients taking GLP-1 agonists

Unlike GLP-1, GIP has little acute ...

Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials